NYtor BV smart molecular diagnostic assay development
NYtor BV has expertise in the development of DNA probes, and already developed and will develop new ones, that are needed for identification of specific DNA sequences. In order to have a device that is ready to be used in practice by end-users, it needs to be robust and easy-to-use.
NYtor designs and develops smart molecular detection assays for a broad range of applications, in collaboration with different partners. Their strength lies in the development of qPCR and point-of-care assays with the main focus on early cancer screening and the detection of pathogens and antibiotic resistance.
